Literature DB >> 12173612

Assessment of pain and health-related quality of life in slowly progressive neuromuscular disease.

Richard T Abresch1, Gregory T Carter, Mark P Jensen, David D Kilmer.   

Abstract

Few studies have examined the effect of pain on the quality of life of individuals with slowly progressive neuromuscular disease (NMD). The purpose of this study was to determine the frequency and extent to which subjects with slowly progressive NMD report pain and the association between pain and health-related quality of life in persons with NMD. The study design was a descriptive, nonexperimental survey. Of a total of 1,432 subjects with slowly progressive NMDs recruited from a university-based NMD clinic and the membership rosters of worldwide NMD support organizations, 859 agreed to participate. The primary measurement tool used was the Medical Outcomes Study SF-36 health survey. Our results indicated that, with the exception of adult spinal muscular atrophy (SMA), the frequency and severity of pain reported in slowly progressive NMDs was significantly greater than levels of pain reported by the general US population and was comparable to pain reported by subjects with osteoarthritis and chronic low back pain. There was a significant correlation between increased pain and lower levels of general health, vitality, social function, and physical role. Pain was moderately associated with increased fatigue, inability to cope adequately with stress, and sleep disturbance. In conclusion, with the exception of adult SMA, the frequency and severity of pain reported in slowly progressive NMDs was significant.

Entities:  

Mesh:

Year:  2002        PMID: 12173612     DOI: 10.1177/104990910201900109

Source DB:  PubMed          Journal:  Am J Hosp Palliat Care        ISSN: 1049-9091            Impact factor:   2.500


  37 in total

1.  Measuring quality of life in muscular dystrophy.

Authors:  Carla M Bann; Richard T Abresch; Barbara Biesecker; Kristin Caspers Conway; Chad Heatwole; Holly Peay; Peter Scal; Jonathan Strober; Karen Uzark; Jodi Wolff; Marjorie Margolis; Angela Blackwell; Natalie Street; Angela Montesanti; Julie Bolen
Journal:  Neurology       Date:  2015-02-06       Impact factor: 9.910

2.  Pain in persons with postpolio syndrome: frequency, intensity, and impact.

Authors:  Brenda L Stoelb; Gregory T Carter; Richard T Abresch; Sophia Purekal; Craig M McDonald; Mark P Jensen
Journal:  Arch Phys Med Rehabil       Date:  2008-10       Impact factor: 3.966

3.  Coping with chronic pain among younger, middle-aged, and older adults living with neurological injury and disease.

Authors:  Ivan Molton; Mark P Jensen; Dawn M Ehde; Gregory T Carter; George Kraft; Diana D Cardemas
Journal:  J Aging Health       Date:  2008

4.  Construction of a Quality of Life Questionnaire for slowly progressive neuromuscular disease.

Authors:  Antoine Dany; Coralie Barbe; Amandine Rapin; Christian Réveillère; Jean-Benoit Hardouin; Isabella Morrone; Aurore Wolak-Thierry; Moustapha Dramé; Arnaud Calmus; Sabrina Sacconi; Guillaume Bassez; Vincent Tiffreau; Isabelle Richard; Benjamin Gallais; Hélène Prigent; Redha Taiar; Damien Jolly; Jean-Luc Novella; François Constant Boyer
Journal:  Qual Life Res       Date:  2015-07-04       Impact factor: 4.147

5.  Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy.

Authors:  Yaroslav Winter; Karsten Schepelmann; Annika E Spottke; Detlef Claus; Christoph Grothe; Rolf Schröder; Dieter Heuss; Stefan Vielhaber; Björn Tackenberg; Veit Mylius; Jens-Peter Reese; Reinhard Kiefer; Bertold Schrank; Wolfgang H Oertel; Richard Dodel
Journal:  J Neurol       Date:  2010-04-10       Impact factor: 4.849

Review 6.  Facioscapulohumeral Dystrophy.

Authors:  Leo H Wang; Rabi Tawil
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

7.  Consensus statement on standard of care for congenital myopathies.

Authors:  Ching H Wang; James J Dowling; Kathryn North; Mary K Schroth; Thomas Sejersen; Frederic Shapiro; Jonathan Bellini; Hali Weiss; Marc Guillet; Kimberly Amburgey; Susan Apkon; Enrico Bertini; Carsten Bonnemann; Nigel Clarke; Anne M Connolly; Brigitte Estournet-Mathiaud; Dominic Fitzgerald; Julaine M Florence; Richard Gee; Juliana Gurgel-Giannetti; Allan M Glanzman; Brittany Hofmeister; Heinz Jungbluth; Anastassios C Koumbourlis; Nigel G Laing; Marion Main; Leslie A Morrison; Craig Munns; Kristy Rose; Pamela M Schuler; Caroline Sewry; Kari Storhaug; Mariz Vainzof; Nanci Yuan
Journal:  J Child Neurol       Date:  2012-03       Impact factor: 1.987

8.  Pain location and intensity impacts function in persons with myotonic dystrophy type 1 and facioscapulohumeral dystrophy with chronic pain.

Authors:  Jordi Miró; Kevin J Gertz; Gregory T Carter; Mark P Jensen
Journal:  Muscle Nerve       Date:  2014-06       Impact factor: 3.217

9.  Patient-identified disease burden in facioscapulohumeral muscular dystrophy.

Authors:  Nicholas E Johnson; Christine Quinn; Eileen Eastwood; Rabi Tawil; Chad R Heatwole
Journal:  Muscle Nerve       Date:  2012-12       Impact factor: 3.217

10.  Charcot-Marie-Tooth disease.

Authors:  Gregory T Carter; Michael D Weiss; Jay J Han; Phillip F Chance; John D England
Journal:  Curr Treat Options Neurol       Date:  2008-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.